← All Sponsors

SPONSOR

Ottawa Heart Institute Research Corporation

Total Trials

4

Recruiting

4

Phases

Phase 3

Conditions studied: Ventricular Tachycardia Ventricular Arrhythmias Ventricular Fibrillation Recurrent Ventricular Tachycardia Atrial Fibrillation Persistent Atrial Fibrillation Paroxysmal Atrial Fibrillation Cardioversion

NCT06281977 Phase 3

Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm

Ventricular Tachycardia

Characterization of Arrhythmia Substrate to Ablate Persistent Atrial Fibrillation

Atrial Fibrillation

Acute Responses to Exercise in Females and Males With Symptomatic Atrial Fibrillation

Atrial Fibrillation

MAX - SHOCK Clinical Trial